Erastin, first identified as killing tumor cells expressing oncogenic RAS, is a classical agent to induce ferroptosis by suppressing cystine/glutamate antiporter (xCT) and leading to decreased cysteine and then inhibiting the function of glutathione peroxidase 4 (GPX4) [4]. Here, SLC7A11 is linked to neoplasm.